Bayer, Onyx drop Nexavar patent suit

23-11-2021

Muireann Bolger

Bayer, Onyx drop Nexavar patent suit

nitpicker / Shutterstock.com

Bayer Healthcare and Amgen subsidiary Onyx Pharmaceuticals have dropped a patent infringement suit against Dr Reddy’s over a planned generic version of cancer treatment Nexavar (sorafenib).


Bayer Healthcare, Onyx Pharmaceuticals, Dr Reddy’s, Generic

LSIPR